WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 7 fonti

Here’s how GLP-1 drugs could save your life, as well as make you slim

GLP-1s may be able to alter the body’s inflammatory and metabolic environment making cancer therapies more effective. Clinical trials will be the next step.

Raccontata dacbsnews.commirror.co.ukindependent.co.ukscientificamerican.commedpagetoday.comafr.comstatnews.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
afr.comStai leggendo8 h fa

Here’s how GLP-1 drugs could save your life, as well as make you slim

GLP-1s may be able to alter the body’s inflammatory and metabolic environment making cancer therapies more effective. Clinical trials will be the next step.

originale

Timeline cronologica

  1. domenica 7 giugno 2026·cbsnews.com

    The promises and pitfalls of GLP-1 drugs

    Approved 20 years ago as a diabetes treatment, GLP-1 drugs have been found to help patients reduce weight, changing the lives of more than 30 million people in the U.S. But there…

  2. lunedì 8 giugno 2026·mirror.co.uk

    Weight loss jabs 'should be probed as cancer prevention agents' after US study

    Scientists say a new study into weight loss drugs like Mounjaro, Wegovy and Ozempiccan suggest the impact of GLP-1 medicines "may reach further and transform how we think about…

scientificamerican.com
16 h fa

Why drugs like Ozempic might reduce cancer risk

A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss

Leggi questa versione → originale
statnews.com6 h fa

AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.

Leggi questa versione → originale
medpagetoday.com13 h fa

Large Study Links GLP-1s to Lower Risk of Multiple Cancers

Patients taking the drugs for obesity had a 41% lower risk of related cancers

Leggi questa versione → originale
independent.co.uk20 h fa

Weight loss jabs linked to dramatic fall in obesity cancer risk

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be…

Leggi questa versione → originale
mirror.co.uk1 g fa

Weight loss jabs 'should be probed as cancer prevention agents' after US study

Scientists say a new study into weight loss drugs like Mounjaro, Wegovy and Ozempiccan suggest the impact of GLP-1 medicines "may reach further and transform how we think about cancer prevention"

Leggi questa versione → originale
  • lunedì 8 giugno 2026·independent.co.uk

    Weight loss jabs linked to dramatic fall in obesity cancer risk

    Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

  • lunedì 8 giugno 2026·scientificamerican.com

    Why drugs like Ozempic might reduce cancer risk

    A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss

  • lunedì 8 giugno 2026·medpagetoday.com

    Large Study Links GLP-1s to Lower Risk of Multiple Cancers

    Patients taking the drugs for obesity had a 41% lower risk of related cancers

  • lunedì 8 giugno 2026·afr.com

    Here’s how GLP-1 drugs could save your life, as well as make you slim

    GLP-1s may be able to alter the body’s inflammatory and metabolic environment making cancer therapies more effective. Clinical trials will be the next step.

  • lunedì 8 giugno 2026·statnews.com

    AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

    AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.